发明名称 Fluoroalkyl-1,4-benzodiazepinone compounds
摘要 Disclosed are compounds of Formula (I): wherein: R2 is phenyl, fluorophenyl, chlorophenyl, trifluorophenyl, methylisoxazolyl, or pyridinyl; R3 is H, CH3, CH2(cyclopropyl), pyridinyl, chloropyridinyl, or methoxypyridinyl: and Ra, Rb, y, and z are defined herein. Also disclosed are methods of using such compounds to inhibit the Notch receptor, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as cancer.
申请公布号 US9133139(B2) 申请公布日期 2015.09.15
申请号 US201314429941 申请日期 2013.09.20
申请人 Bristol-Myers Squibb Company 发明人 Gavai Ashvinikumar V.;Shan Weifang;Balog James Aaron;Quesnelle Claude A.;Han Wen-Ching;DeLucca George V.;O'Malley Daniel;Fink Brian E.
分类号 C07D413/14;C07D401/04;C07D401/12;C07D413/12;C07D243/24;A61K31/5513;C07D491/056;A61K45/06 主分类号 C07D413/14
代理机构 代理人 Greenblatt Gary D.
主权项 1. A compound of Formula (I): wherein: R2 is phenyl, fluorophenyl, chlorophenyl, trifluorophenyl, methylisoxazolyl, or pyridinyl; R3 is H, —CH3, —CH2(cyclopropyl), pyridinyl, chloropyridinyl, or methoxypyridinyl; each Ra is independently F, Cl, —CH3, —OCH3, —CN, and/or —O(cyclopropyl); or two adjacent Ra along with the carbon atoms to which they are attached form a dioxole ring; each Rb is independently F, Cl, —CHF2, and/or —CF3; y is zero, 1, or 2; and z is zero, 1, or 2.
地址 Princeton NJ US